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Abstract
Background: It has been recently demonstrated that CD8+ T-lymphocyte numbers are
genetically transmitted in association with the MHC class I region. The present study was designed
with the objective of narrowing the region associated with the setting of CD8+ T-lymphocyte
numbers in a population of C282Y homozygous hemochromatosis subjects, in whom a high
prevalence of abnormally low CD8+ T-lymphocyte counts has been described.
Methods: The study includes 43 C282Y homozygous subjects fully characterized both
phenotypically and genotypically. Clinical characterization includes measurements of iron
parameters at diagnosis (transferrin saturation and serum ferritin), total body iron stores and T-
cell immunophenotyping determined by flow cytometry. Genetic characterization includes HLA
class I alleles (A, B and C) and four additional microsatellite markers (D6S265, D6S2222, D6S105
and D6S2239) spanning 5 Megabases in the 6p21.3 region.
Results: Eighty-two extended C282Y carrying haplotypes were defined. Single-locus analysis
revealed that the HLA-A region was associated with CD8+ T-cell numbers. Multivariate analysis
showed that the combinations of the most common HLA-A alleles (HLA-A*03, -A*02 and -A*01)
were associated with significantly lower numbers of CD8+ T-lymphocytes (0.30 ± 0.14 × 106/ml),
in comparison with subjects carrying only one copy of those alleles (0.46 ± 0.19 × 106/ml) and
subjects without any copy of those alleles (0.79 ± 0.15 × 106/ml;p = 0.0001). No differences were
observed in CD8+ T-cell counts among control subjects carrying the same combinations of HLA-
A alleles (0.47 ± 0.14; 0.45 ± 0.21 and 0.41 ± 0.17 × 106/ml, respectively), therefore not supporting
a direct effect of HLA specificity but rather an indirect association with a locus close to HLA-A.
Multivariate analysis showed that the combination of the most common HLA-A alleles also have an
impact on the clinical expression of HH in terms of iron stores, in males(p = 0.0009).
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BMC Medical Genetics 2006, 7:16 http://www.biomedcentral.com/1471-2350/7/16Conclusion: The present study provides evidence supporting an inextricable link between
extended HLA haplotypes, CD8+ T-lymphocyte numbers and severity of iron overload in
hereditary hemochromatosis(HH). It gives additional information to better define a candidate
region involved in the regulation of CD8+ T-lymphocyte numbers. A new evolutionary hypothesis
concerning the inheritance of the phenotype of low CD8+ T-lymphocyte numbers associated with
particular ancestral HLA haplotypes carrying the C282Y mutation and its implication on the clinical
heterogeneity of HH is discussed.
Background
There are multiple regulatory mechanisms influencing
peripheral blood lymphocyte numbers that are responsi-
ble for the maintenance of cell numbers in homeostasis
[[1] and reviewed in ref [2]]. An increasing number of
studies in the last years, both in humans and animal mod-
els, point to the involvement of genetic factors in the reg-
ulation of CD4 and CD8 T-lymphocyte numbers. In mice,
the first study addressing this question showed that the
phenotype of low CD4/CD8 ratio was a dominant Men-
delian character and was significantly influenced by age
[3]. Later studies in mice showed a locus regulating CD4/
CD8 ratios localized in or near the TCR α-chain complex
region and a significant association with the Major Histo-
compatibility Complex (MHC) region [4]. Moreover, dif-
ferences in CD4/CD8 ratios could be explained by
variations in the process of CD4 versus CD8 lineage com-
mitment in the thymus [5]. While in mice CD4/CD8
ratios appear to be independent of thymic intrinsic factors
[5], in rats CD4/CD8 ratios are determined by thymic fac-
tors intrinsic to the strain [6], supporting the hypothesis
that such factors are genetically determined.
Studies in humans have also revealed a genetic regulation
for CD4/CD8 numbers. Complex segregation analysis of
the CD4/CD8 ratios in nuclear families, suggested a major
recessive locus with a polygenic component and addi-
tional environmental effects for the control of CD4/CD8
ratios [7]. The two components of this ratio were later
shown to be regulated by major recessive genes control-
ling CD4 and CD8 absolute counts, with a residual multi-
factorial component [8]. A study in monozygotic and
dizygotic twins indicates that T-lymphocyte subpopula-
tions have a main genetic control with unique environ-
mental component and significantly influenced by age
[9]. More recent efforts to find genes associated with the
regulation of lymphocyte numbers and subpopulations
have been made using whole genome screen approaches
[10,11]. Using 15 Center D'Etude Du Polymorphisme
Humain (CEPH) families it was shown that lymphocyte
counts, B cells, natural killer cells, and CD4 and CD8
counts, were all under significant genetic control, with the
CD8+ T-cell counts being the most heritable trait [10]. Sig-
nificant levels of linkage were found between these cell
counts and chromosomes 1, 2, 3, 4, 8, 9, 11, 12 and 18.
No linkage was found for chromosome 6, where the MHC
is located, although the authors discuss that the HLA
region is still an obvious candidate region [10]. Using 405
pairs of dizygotic twins at ages of 12, 14 and 16, it was
found suggestive evidence of linkage on chromosome 11p
at ages of 12 and 14 [11]. In addition, suggestive evidence
of linkage was found in other areas of the genome includ-
ing chromosome 6q (microsatellite markers D6S1031-
D6S462) [11]. All these studies constitute good evidence
showing a genetic regulation for CD4 and CD8 numbers
although do not provide evidence to confirm the linkage
to MHC found in animal models. The involvement of the
MHC region on this regulation was first demonstrated in
humans in our recent study of the genetic transmission of
CD8+ T lymphocytes [12]. The approaches used in that
study included association studies between the CD4+ and
CD8+ T-lymphocyte counts and the HLA class I alleles (A
and B) in an unrelated healthy population, and a sibpair
analysis using a population of HLA class I and HFE geno-
typed subjects belonging to hereditary hemochromatosis
(HH) families [13]. A strong significant association of the
HLA-A*01 with high numbers of CD8+ T cells was found
in the unrelated healthy population [12]. Sibpair correla-
tion in families showed a strong impact of the HLA-HFE
haplotypes on the setting of CD8+ T-lymphocyte numbers
but not of CD4+ [12]. Based on these results and also on
our previous results showing an association between low
CD8+ T-lymphocyte numbers and a more severe expres-
sion of iron overload in HH [14-17], we further advanced
the hypothesis that gene(s) contributing to the clinical
heterogeneity observed in HH could be genes that also
control CD8+ T-cell numbers [12]. This might partially
explain the great clinical heterogeneity observed in HH
patients [18-22] and further explain the possibility that
modifier genes, other than HFE, are responsible for this
phenotypic variation, in accordance with other studies
[23,24].
In the present study we attempt to narrow the region asso-
ciated with the setting of CD8+ T-lymphocyte numbers
using a population of C282Y homozygous subjects fully
characterized both phenotypically and genotypically.
Multivariate models were used to test the association
between several genetic markers at the MHC region and
CD8+ T-lymphocyte numbers, as well as the impact ofPage 2 of 12
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HH. We discuss the hypothesis that the phenotype of low
CD8+ T-lymphocyte numbers in HH is inherited in asso-
ciation with particular ancestral HLA haplotypes carrying
the C282Y mutation.
Methods
Study population
C282Y homozygous subjects
A total of 43 hereditary hemochromatosis probands, all
homozygous for the C282Y mutation, identified between
1985 and 2004 and regularly followed up at the Hemo-
chromatosis Outpatient Clinic of Santo António General
Hospital (HGSA), Porto and at Predictive and Preventive
Genetic Center, Porto, have been included in this study.
The subjects are all Caucasian from the North of Portugal
and include 32 males (mean age at diagnosis = 50 ± 14
years; range 23–75) and 11 females (mean age at diagno-
sis = 47 ± 12 years; range 32–65) (Table 1). In 25
probands, C282Y homozygozity was detected in the con-
text of suggestive clinical picture of hemochromatosis,
generally with related clinical manifestations and in 18,
C282Y homozygozity was detected accidentally after a
routine test or in the context of a population screening for
HH, in whom transferrin saturation (TfSat) and/or serum
ferritin were abnormally elevated according to local refer-
ence values [25,26] and generally asymptomatic. Clinical,
laboratory and genetic data included in this work were
partially reviewed from the clinical files of the subjects or
were determined for this study, with the informed consent
of the subjects according to the Helsinki declaration. The
study design was approved by the Hospital Ethical Com-
mittee. Clinical and laboratory data from patients have
been published elsewhere [16,27,28].
Severity of HH was evaluated by the calculation of
exchangeable iron stores. Thirty-six patients had com-
pleted a weekly phlebotomy program until complete iron
depletion was achieved (TfSat below 10% and/or ferritin
levels below 10 ng/ml). Total body iron stores (TBIS) were
a posteriori estimated, based on the total amount of hemo-
globin removed by phlebotomies with correction for the
amount of iron absorbed during the treatment period, as
described [29]. In 7 probands (5 males and 2 females)
TBIS were not included because patients were treated in
Table 1: General characterization of C282Y homozygous probands at the time of diagnosis according to gender
Males n = 32 Females n = 11 p*
Age (years) 51 ± 13 (29–75) 47 ± 11 (32–65) n.s.
Transferrin Saturation (%) 92 (87–97) 83 (75–92) n.s.
Ferritin (ng/ml) 2694 (2006–3383) 1353 (122–2584) n.s.
Total Body Iron Stores (g) 9.86 (8.19–11.54) 6.11 (3.21–9.02) 0.030
Total lymphocytes (×106/ml) 1.91 (1.69–2.13) 2.30 (1.92–2.67) n.s.
Total CD4+ cells(×106/ml) 0.98 (0.84–1.11) 1.09 (0.85–1.32) n.s.
Total CD8+ cells(×106/ml) 0.35 (0.28–0.42) 0.48 (0.36–0.59) n.s.
Parameters are expressed as mean (95% confidence intervals) except age, which is expressed as mean ± standard deviation (maximum – minimum 
values).
Estimation of TBIS was obtained in 27 males and 9 females.
*Statistically significant differences between groups (p) were tested using Student's T test.
Physical map of the polymorphic markers used in the present study and their relative localization (at scale) in relation to HLA-A, B and C and HFEFigure 1
Physical map of the polymorphic markers used in the present study and their relative localization (at scale) in relation to HLA-
A, B and C and HFE.
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TBIS.
Control population
Data from 264 apparently healthy unrelated subjects, pre-
viously analyzed by Cruz and co-workers [12], were
included in this study. The population consisted of 116
males (mean age 43 ± 13 years, range 20 to 76) and 148
females (mean age 45 ± 13 years, range 18 – 88), from
whom the previously determined total CD4+ and CD8+
T-cell numbers, HFE genotype and HLA-A, -B and -C gen-
otype were available. This population was used to com-
pare CD8+ T-lymphocyte numbers according to the HLA-
A and -B class I alleles between controls and C282Y
homozygous subjects. In addition, control subjects carry-
ing the HLA-A*01 (n = 47) were genotyped for the micro-
satellite markers D6S2222 and D6S105. This
subpopulation was used to compare the allele frequencies
of these microsatellites between controls and C282Y
homozygous, all carrying the HLA-A*01.
Genetic characterization of C282Y homozygous subjects 
and haplotype definition
All probands were previously genotyped for the HFE
mutations (H63D and C282Y) and were all homozygous
for the C282Y mutation. HLA class I alleles (A, B and C)
were available in all probands except the HLA-C in 3 sub-
jects. In addition, four polymorphic markers in the MHC
class I region were selected for the definition of extended
HLA haplotypes. These include microsatellites spanning 5
Megabases in the 6p21.3 region, from the HLA-B to the
HFE: D6S265, D6S2222, D6S105, and D6S2239 (Figure
1).
HLA A-B haplotypes and extended HLA haplotypes
(including the 4 microsatellite markers) were defined in
C282Y homozygous subjects by segregation in families.
Haplotypes were defined from the combination of alleles
inherited in blocks from each parent or from informative
siblings, when any of the parents was not available.
Genetic markers included in extended HLA haplotypes
were aligned according to physical map of the region as
follows: HLA-B, HLA-C, D6S265, HLA-A, D6S2222,
D6S105, C282Y mutation, D6S2239 (Figure 1). A total of
86 HLA A-B haplotypes and 82 extended HLA haplotypes
could be defined. In two probands the microsatellite gen-
otyping could not be performed because there was no
DNA available. Both probands had the HLA A-B haplo-
types: A*03-B*07 and A*02-B*51.
Laboratory methods
Biochemical parameters of iron status used in this work
include determinations, at the time of the diagnosis, of
TfSat and serum ferritin. These parameters are routinely
determined by standard techniques at the Clinical Chem-
istry Laboratory of HGSA, Porto, as previously described
[28]. The T-cell immunophenotype analyzed include total
lymphocyte counts and total CD4+ and CD8+ T-lym-
phocyte counts. Total lymphocyte counts were deter-
mined in an automatic blood cell counter (Coulter Gen S)
and the CD4 and CD8 + T-lymphocyte counts were deter-
mined by flow cytometry, as described in detail elsewhere
[12]. HFE genotyping was performed using a commercial
kit, the Haemochromatosis StripASSAYB (Vienna Lab,
Vienna, Austria) as described before [12]. HLA-A and B
alleles were detected using low-resolution DNA-based
techniques (PCR/sequence-specific oligonucleotide
probes, Dynal RELI™ SSO) as previously described [12].
Microsatellite genotyping was performed at the North
Histocompatibility Center, Portugal. Genomic DNA was
used and the genotyping was done in an ABIPrism 3100
Avant DNA Sequencer. Fluorescent labeled primers were
obtained from ABI and were: for D6S265 5'-acgttcgtac-
ccattaacct-3' (forward primer) and 5'-atcgaggtaaacagca-
gaaa-3' (reverse primer); D6S2222 5'-agtcatctgaagagttgg-3'
(forward primer) and 5'-gcatgtcttctttgttaagg-3' (reverse
primer); for D6S105 5'-gggattacaggcaggagccac-3' (forward
primer) and 5'-gaaggagaattgtaattccg-3' (reverse primer)
and for D6S2239 5'-gttggaagcaatggattagatgtcc-3' (forward
primer) and 5'-ctacctgccaggaacaatatacac-3' (reverse
primer). Amplification was performed according to an
established protocol. Briefly, Amplitaq gold (Perkin-
Elmer) was used to amplify specific amplicons, using
genomic DNA as template. Amplification was performed,
in all cases, with an initial denaturation step of 94°C (8
minutes), followed by 30 cycles at 94°C (15 sec.), 55°C
(15 sec.) and 72°C (30 sec.), and a final extension step of
30 minutes at 72°C. Alleles were identified by electro-
phoresis on sequencing gels. The classification adopted
for each microsatellite allele is based on the size (in base
pairs) of each DNA fragment amplified.
Statistical considerations
Group means were compared by the Student T-test when
two groups were analyzed or by the one-way analysis of
variance test (ANOVA) when more than two groups were
analyzed. The Chi-square test was used to test the fitness
of data to the normal distribution. Independence between
categorical data and differences between allele frequencies
of the genetic markers between the hemochromatosis
patients and the control population were tested using the
Chi-Square test.
Two different sets of analyses were done in C282Y
homozygous subjects to investigate the impact of the
genetic markers from the 6p21.3 region, on the CD8+ T-
lymphocyte numbers. First, a single-locus analysis was
performed by one-way ANOVA, where the numbers of
CD8+ T lymphocytes were analyzed in relation to the alle-
les of each genetic marker studied (HLA-A, -B and -C andPage 4 of 12
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Multi-locus map of C282Y carrying haplotypes from a region spanning 5 Megabases from HLA-B to D6S2239Figure 2
Multi-locus map of C282Y carrying haplotypes from a region spanning 5 Megabases from HLA-B to D6S2239. The allele specif-
icity in each locus is represented by numbers corresponding to the size of the amplified DNA fragments. Color boxes repre-
sent conserved haplotype areas. n.d.: not determined.
HLA-B HLA-C  D6S265  HLA-A  D6S2222 D6S105  HFE    D62239
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D6S2239). Single-locus analyses were also done for CD4+
T-lymphocyte and total lymphocyte numbers. Since each
subject carries two chromosomes and therefore two differ-
ent allele specificities, a second set of analysis was done
considering the combination of the two inherited HLA-A
alleles. For this purpose a trichotomous variable denomi-
nated "HLA-A genotype" (details in the result' section),
was created and its impact on the variability of CD8+ T
lymphocytes was also analyzed using a stepwise multiple
regression analysis. In this model, CD8+ T lymphocytes
were set as dependent variable and the HLA-A genotype,
age, gender and iron measures (TfSat, serum ferritin and
TBIS) were used as independent variables. Because serum
ferritin values were not normally distributed, a log trans-
formation was used for this variable.
To investigate the effect of the "HLA-A genotype" on the
severity of the disease, in terms of iron stores (TBIS), a
stepwise multiple regression model was used. TBIS was set
as dependent variable and the HLA-A genotype as inde-
pendent variable, together with age and gender. The inter-
action of the variable gender with the other independent
variables was tested by introducing two dummy variables
in the model, corresponding to male or female gender.
The overall fit of ANOVA is indicated by F and p values.
The overall fit of multiple regression model is indicated by
the full regression R2, and the F and p values of each vari-
able in the model. All statistical tests were performed at
the 0.05 level of significance and all p values are two-
sided. Data were analyzed by Statgraphics software (Stat-
graphics Graphics System, version 7.0).
Results
General characterization of C282Y homozygous probands
In the group of 43 C282Y homozygous probands all had
TfSat above 65% at the time of the diagnosis. There was,
however, a great variability in serum ferritin levels and
also in the amount of iron removed by phlebotomies
(TBIS) (Table 1). Although males presented with higher
average values for TfSat, serum ferritin and TBIS than
females, values only reached statistical significance for
TBIS (Table 1). No significant differences were observed
in the numbers of total lymphocytes and CD4+ and CD8+
T lymphocytes between males and females, although the
lowest values of CD8+ T-cell counts were observed in
males (Table 1). The proportion of patients who showed
CD8+ counts below the median (previously established in
a control population = 0.41 × 106/ml [12]), was 75% (24/
32) in males and 36% (4/11) in females.
Genetic characterization of C282Y homozygous probands
HLA A-B haplotypes
A total of 86 HLA A-B haplotypes were defined by segrega-
tion in families from the 43 homozygous probands
included in the study. Thirty-seven different HLA A-B hap-
lotypes could be identified. These are shown in Figure 2.
As expected, the haplotype A*03-B*07 was the most com-
mon (22/86; 0.256), being present in 44% (19/43) of the
subjects, 16 in heterozygozity and 3 in homozygozity. The
next most common haplotypes were the A*03-B*35 (7/
86; 0.081) and A*01-B*08 (6/86; 0.070), followed by
A*02-B*51 and A*02-B*07 (each haplotype present in 4/
86; 0.047). Haplotypes A*02-B*44, A*23-B*44 and
A*32-B*60 were present in three probands each (3/86;
0.035). All the other 28 haplotypes had frequencies below
0.025 and 22 of the haplotypes were represented only
once (see Figure 2).
Extended HLA haplotypes
A total of 82 extended HLA haplotypes could be defined
from the 43 hemochromatosis probands (see Methods).
Haplotypes were aligned taking into account the HLA-A
and then arbitrarily according to the similarity of the alle-
les from the several microsatellites. The predominant
extended HLA haplotype carries the HLA-A*03-B*07 and
is defined by: HLA-B*07, HLA-C*07, D6S265-128, HLA-
A*03, D6S2222-247, D6S105-150, HFE-C282Y,
D6S2239-112 (Figure 2). This haplotype is present in 14/
82 (17%) of subjects. Clearly, the most conserved region
spans from HLA-A to D6S2239, where the A*03 carrying
haplotypes defined by HLA-A*03, D6S2222-247,
D6S105-150, HFE-C282Y, D6S2239-112 is present in
35% (29/82) of the chromosomes (Figure 2). Two other
common haplotypes, carrying the HLA-A*02 and A*01,
were found. The haplotype HLA-A*02, D6S2222-247,
D6S105-150, HFE-C282Y, D6S2239-112 is present in
13% (11/82) and the haplotype HLA-A*01, D6S2222-
247, D6S105-150, HFE-C282Y, D6S2239-112 is also
present in 13% (11/82) of the chromosomes (Figure 2).
The higher frequency of the HLA-A*03, -A*02 and -A*01
carrying haplotypes, as well as their relative lower micros-
atellite diversity (illustrated in Figure 2) suggest that these
haplotypes are older in the evolutionary history of the
C282Y mutation in this population.
Single-locus analysis of genetic markers from the MHC 
region in relation to CD8+ T lymphocytes from C282Y 
homozygous probands
The numbers of CD8+ T lymphocytes were analyzed in
relation to single-locus HLA-A, -B, -C alleles and microsat-
ellites D6S265, D6S2222, D6S105, D6S2239 alleles, by
one-way ANOVA. A statistically significant effect (F =
2.36, p = 0.013, one-way ANOVA) of the HLA-A alleles on
the CD8+ T-cell numbers was found. Among all HLA-A
specificities, the A*03 (n = 39), A*02 (n = 16) and A*01Page 6 of 12
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cell counts. This effect is more clearly evidenced when all
chromosomes carrying HLA-A alleles other than A*03,
A*02 and A*01 (chromosomes carrying A*11, A*23,
A*24, A*25, A*26, A*29, A*31, A*32, A*33 and A*68; n
= 18) are pooled together in one group as illustrated in
Figure 3 (F = 5.58, p = 0.0016, one-way ANOVA). No sta-
tistically significant associations were found with any of
the more centromeric markers, D6S265, HLA-C and HLA-
B. No significant associations were also found with the tel-
omeric markers D6S2222, D6S105 and D6S2239, an
expected result taking into consideration the high conser-
vation of the region as evidenced by the presence of the
same microsatellite alleles in the large majority of C282Y
carrying chromosomes.
A statistically significant result (F = 3.21, p = 0.027, one-
way ANOVA) was observed when the effect of the HLA-A
was tested on total lymphocyte counts (data not shown).
No statistically significant associations were found for
total lymphocyte counts with any of the other markers
used. No statistically significant effect was found on the
numbers of CD4+ T cells and any of the genetic markers
tested (data not shown).
The combined effect of the two inherited HLA-A alleles on 
the CD8+ T-lymphocyte numbers from C282Y homozygous 
probands
To further investigate the association found between par-
ticular HLA-A alleles in chromosomes carrying the C282Y
mutation and the number of CD8+ T cells, C282Y
homozygous subjects were divided according to the com-
bination of the two inherited HLA-A alleles. This created a
trichotomous variable, from now on denominated "HLA-
A genotype", dividing C282Y homozygous probands in
the following groups: 1.subjects with two copies of the
most common HLA-A alleles (A*03, A*02 and A*01; n =
27); 2.subjects with only one copy of the most common
HLA-A alleles (n = 14) and 3.subjects without any copy of
those alleles (n = 2). A stepwise multiple regression anal-
ysis was run, where the number of CD8+ T lymphocytes
was set as dependent variable and the HLA-A genotype,
iron measures (TBIS, TfSat and serum ferritin), age and
gender (dummy variable), were set as independent varia-
bles. The only variable significantly affecting CD8+ T-cell
numbers was the HLA-A genotype (F = 20.56 and p =
0.0001). The R2 for the full regression was 0.37. Iron
related variables did not enter the model (F = 1.78 for
TBIS; F = 0. 848 for TfSat and F = 0.201 for ferritin). Gen-
der and age also did not enter the model (F = 1.16 and F
= 0.123, respectively). Due to the fact that there are only
two subjects without any copy of the most common HLA-
A alleles and these two had the highest CD8+ numbers, a
new regression was run where the HLA-A genotype varia-
ble was analyzed only with the groups of subjects with
either two copies of the most common HLA-A alleles (n =
27) or with only one copy of those alleles (n = 14). A sta-
tistically significant effect of the HLA-A genotype on
CD8+ T-cell numbers was maintained (F = 7.98 and p =
0.0082).
The effect of the HLA-A genotype on CD8+ T lymphocytes
is illustrated in Figure 4A. Subjects carrying two copies of
the most common HLA-A alleles (A*03, A*02, A*01) pre-
sented the lowest average CD8+ T-cell numbers (0.30 ±
0.14 × 106/ml) and subjects without any copy of the most
common HLA-A alleles presented the highest average
value (0.79 ± 0.15 × 106/ml). Subjects with only one copy
of the most common HLA-A alleles presented intermedi-
ate average CD8+ T-cell numbers (0.46 ± 0.19 × 106/ml).
The effect of HLA-A alleles on the CD8+ T-lymphocyte 
numbers from control subjects
The results described in C282Y homozygous probands
confirm an association of the HLA-A region with the set-
ting of CD8+ T lymphocytes. Since CD8+ T lymphocytes
are known to expand in the context of MHC class I mole-
cules, it is plausible to consider that the HLA specificity
itself could be responsible for the results observed. To test
this hypothesis, we examined retrospectively the effect of
the combinations of HLA-A alleles on CD8+ T-cell num-
bers in a previously studied control population, not carry-
ing the C282Y mutation [12]. Control subjects were
grouped according to the same combinations of alleles
Mean values ± standard error of the mean of the CD8+ T-lymphocyt  numbers acco ding to the presence of different HLA-A all les among haplotypes carrying the C282Y muta-tionFigure 3
Mean values ± standard error of the mean of the CD8+ T-
lymphocyte numbers according to the presence of different 
HLA-A alleles among haplotypes carrying the C282Y muta-
tion. Haplotypes carrying the HLA-A*01 are 13, the A*02 are 
16 and the A*03 are 39. The group of "All other A" specifici-
ties include: HLA-A*11, A*23, A*24, A*25, A*26, A*29, 
A*31, A*32, A*33 and A*68 and are 18.
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BMC Medical Genetics 2006, 7:16 http://www.biomedcentral.com/1471-2350/7/16used in C282Y homozygous subjects. In contrast with the
C282Y homozygous population, no differences were
observed among control subjects carrying combinations
of A1, A2 or A3 alleles (0.47 ± 0.14 × 106/ml, n = 65), con-
trol subjects carrying only one copy of these alleles (0.45
± 0.21 × 106/ml, n = 31) and subjects without any copy of
those alleles (0.41 ± 0.17 × 106/ml, n = 14), therefore not
supporting a direct effect of the HLA specificity on the
results. In the previously described control population
[12], subjects carrying the HLA-A*01 had significantly
higher CD8+ T-lymphocyte numbers, a result apparently
in contradiction with what was described in the present
work, where C282Y homozygous probands carrying the
A*01 have lower CD8+ T-cell counts. To address this
question we genotyped control subjects carrying the HLA-
A*01 (n = 47) for the microsatellites D6S2222 and
D6S105 and calculated frequencies of the alleles 247 and
150, which were found consistently associated in the hap-
lotypes carrying the C282Y mutation (allele frequencies
are respectively 0.875 and 0.958). In contrast with C282Y
homozygous, the most commonly found allele of the
microsatellite D6S2222 in control subjects carrying the
HLA-A*01, was not the 247 (32/94; allele frequency =
0.340) but rather the 249 (45/94; allele frequency =
0.479). This difference in allele frequencies was statisti-
cally significant (p < 0.00001). For the microsatellite
D6S105, although the allele 150 was the most common in
both groups, its allele frequency was significantly lower (p
= 0.0001) in controls (47/94; allele frequency = 0.500)
than in C282Y homozygous (23/24; allele frequency =
0.958).
Impact of the HLA-A genotype on the clinical expression 
of HH
In face of the results showing an impact of the HLA-A
region on the setting of the CD8+ T-cell numbers and the
previously described association of low CD8+ T cells with
a more severe expression of iron overload [16,17], we
reinforce the hypothesis that a putative gene controlling
CD8+ T-lymphocyte numbers could be a modifier of the
clinical expression in hemochromatosis [12]. To further
investigate this hypothesis we tested the effect of the HLA-
A genotype in the levels of TBIS by stepwise multiple
regression analysis. For this purpose, the variable TBIS was
taken as dependent and HLA-A genotype, age and gender
(dummy variables) as independent variables. The varia-
bles entering into the model were age and HLA-A geno-
type only in males (F = 17.29 and F = 7.16, respectively).
The R2 for the full regression was 0.306 and the global sig-
nificance level was 0.0009. This result is illustrated by the
correlation between HLA-A genotype and residual values
of TBIS on age in males, as shown in Figure 4B. However,
if the number of CD8+ T lymphocytes is introduced in the
model, the effect of HLA-A genotype is lost, and the only
significant variables entering the model are age and CD8+
T cells in males (F = 16.54 and F = 7.58, respectively). The
R2 for the full regression is similar (0.303; p = 0.0012).
This result shows that the effect of the HLA-A region on
the severity of iron stores may be confounded by the
number of CD8+ T lymphocytes.
Discussion
The present study was designed to further investigate our
previous results showing that CD8+ T-lymphocyte num-
bers are under the control of genes localized at the MHC
region. An attempt to narrow the candidate region is
made, using as a model 43 HH subjects, C282Y
homozygous, in whom a high proportion of subjects have
low CD8 + T-cell numbers. The results provide evidence
supporting an inextricable link between extended HLA
haplotypes, CD8+ T-lymphocyte numbers and severity of
iron overload in HH.
The HLA-A region is associated with the low CD8+ T-
lymphocyte trait in HH
Single-locus analysis of the several genetic markers of the
MHC region in chromosomes carrying the C282Y muta-
Distribution of the CD8+ T-lymphocyte numbers (A) and of the total body iron store ( BIS) after correction for the eff ct of age (residuals of TBIS on age) (B), in males, accord-ing the HLA-A gen type of the C282Y homozygous probands, which ivide subjects in the three gr up : 1Fi ure 4
Distribution of the CD8+ T-lymphocyte numbers (A) and of 
the total body iron store (TBIS) after correction for the 
effect of age (residuals of TBIS on age) (B), in males, accord-
ing to the HLA-A genotype of the C282Y homozygous 
probands, which divide subjects in the three groups: 1.sub-
jects with two copies of the most common HLA-A alleles 
(A*03, A*02 and A*01; n = 27); 2.subjects with only one copy 
of the most common HLA-A alleles (n = 14) and 3.subjects 
without any copy of those alleles (n = 2).
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ciated with the HLA-A region. No significant association
was found with the more telomeric markers, spanning
from the microsatellites D6S2222 to D6S2239. This
region is well conserved in all haplotypes, independently
of CD8+ T-cell numbers. Centromerically to HLA-A, a
high allele diversity is observed and no association was
found with CD8+ T-cell numbers (Figure 2). Therefore, a
putative genetic marker of CD8+ T-lymphocyte numbers
could be localized between D6S2222 and HLA-A. Since
each individual, with a particular CD8+ T-cell profile, has
two different HLA-A alleles, it may be expected that the
CD8+ profile will be the result of the combined effect of
the two chromosomes. Indeed, we found that, in the
C282Y background, the inheritance of two of the most
common HLA-A alleles (A*03, A*02 and A*01) is associ-
ated with a low CD8+ T-lymphocyte profile and the inher-
itance of only one of those alleles is associated with higher
CD8+ T-lymphocyte profile (0.30 ± 0.14 versus 0.46 ±
0.19 × 106/ml). The highest value of CD8+ T-cell numbers
was observed in the subjects without any copy of the most
common HLA-A alleles (0.79 ± 0.15 × 106/ml). The most
attractive hypothesis to explain these results is the exist-
ence of a genetic trait associated with low CD8+ T-lym-
phocyte numbers localized in the HLA-A region. In this
case, the trait would be in linkage with haplotypes carry-
ing the A*03, A*02 or A*01 in the C282Y background. In
a previous report, Pratiwi and collaborators [24] showed,
by an extended linkage disequilibrium analysis in the
hemochromatosis gene region, two distinct peaks of asso-
ciation separated by 2 Megabases and referred that "such
did not describe the expected pattern for a single gene dis-
order" [24]. The authors found a highly significant associ-
ation at D6S2239, localized in close proximity to HFE (14
kilobases telomeric) and at D6S105, located about 200
kilobases away from the D6S2222 [24]. The possibility
that the results described by Pratiwi and co-workers corre-
spond to the presence of the same genetic trait described
here is highly attractive. The finding of low CD8+ T-cell
counts associated with HLA-A*01 carrying haplotypes is
also in accordance with the recently reported association
of low total lymphocyte counts with the HLA haplotype
A*01-B*08 in an independent population of hemochro-
matosis patients from Alabama [30].
The possibility that the present results are due to the effect
of the HLA specificity itself must be considered. In a con-
trol population not carrying the C282Y mutation, how-
ever, combinations of the same HLA-A alleles, as observed
in patients, did not reveal the same association with CD8+
T-cell numbers, constituting an argument against this pos-
sibility. This does not exclude a possible interaction
between HFE and HLA, as recently suggested in a study of
MHC class I expression in peripheral blood mononuclear
cells from patients carrying the C282Y mutation [31].
The association of low CD8+ T-lymphocyte counts with
HLA-A*01 in C282Y carrying subjects, seemed to be in
contradiction with our own previous work, where it was
shown that the majority of HLA-A*01 normal subjects
had high numbers of CD8+ T lymphocytes [12]. However,
it is likely that the association with high or low CD8+ T-
cell counts is not dependent on the HLA-A*01 specificity
itself but rather on another putative marker inherited in
linkage with particular haplotypes, depending on the
recombination history of the region. Microsatellite mark-
ers in the region close to HLA-A (D6S2222 and D6S105)
showed that the HLA-A*01 carrying haplotypes are not
the same in chromosomes carrying or not the C282Y
mutation. In the case of A*01, D6S2222-247, D6S105-
150, C282Y haplotypes, there is a clear association with
low CD8+ T-lymphocyte counts, in contrast with A*01
haplotypes in the normal population that do not carry the
C282Y mutation. These results support the hypothesis
that inherited mutations in a putative gene controlling
CD8+ T-cell numbers could be differentially transmitted
in chromosomes carrying or not the C282Y mutation.
Implications on the clinical heterogeneity of HH
The inheritance of different HLA-A alleles also influenced
the clinical severity of the disease, in terms of iron
removed by phlebotomy. Multivariate analysis of TBIS
with HLA-A genotype, age and gender, showed an associ-
ation of the HLA-A genotype with TBIS and in particular
with the degree of iron accumulation with age in males
(Figure 4B), in accordance with results previously
reported by other authors [32-35]. In addition, in a mul-
tiple regression model it was shown a stronger effect of the
CD8+ T-lymphocyte counts in accordance with our own
previously reported data [16]. Altogether the results sup-
port the notion that gene(s) in this region contribute both
to the control of CD8+ T-cell numbers and the clinical
heterogeneity observed in HH (Figure 4A and 4B). The
question remains if these associations are explained by
one single gene or by independent genes in linkage dise-
quilibrium in the same locus. The search for possible
recombinants defined by genotype/phenotype discrepan-
cies may help in future to elucidate this question.
Evolutionary hypothesis concerning a genetic trait of low 
CD8+ T lymphocytes in HH subjects
Based on the definition of 82 extended HLA haplotypes in
C282Y homozygous subjects we would like to advance an
evolutionary hypothesis to explain the high frequency of
abnormally low CD8+ T-lymphocyte numbers in HH. The
predominant extended HLA haplotype found in the
present population, carries the HLA A*03-B*07 (Figure
2), assumed to be the ancestral haplotype where the muta-
tion was originated. We found a clear association between
low CD8+ T-cell counts and the HLA-A*03, suggesting
that the original chromosome where the C282Y appearedPage 9 of 12
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BMC Medical Genetics 2006, 7:16 http://www.biomedcentral.com/1471-2350/7/16carried the A*03-B*07 and also the genetic trait associated
with low CD8+ T lymphocytes. As described before by
Simon and collaborators [36] recombination events of the
HH haplotypes, first occurred centromerically to HLA-A,
originating a multiplicity of HLA-A*03 carrying haplo-
types. Recombination between the ancestral haplotype
and rare haplotypes in the population are less likely to
occur than recombinations between an ancestral haplo-
type and common haplotypes. Thus, it is likely that more
telomeric recombinations introduced the HLA-A*02 and
-A*01 alleles, the most common alleles found in the con-
trol population [12], giving rise to A*02 and A*01 haplo-
types carrying the C282Y mutation that, conceivably, are
also ancestral haplotypes in the evolutionary history of
the C282Y mutation. These haplotypes still maintain the
characteristic of low CD8+ T lymphocytes considering
that the putative gene controlling these numbers is local-
ized telomerically to HLA-A. Subsequent recombination
events between HLA-A and the D6S2222 may lead to the
appearance in the C282Y carrying haplotypes of HLA-A
alleles less frequently found in the control population
(A*11, A*23, A*24, A*25, A*26, A*29, A*31, A*32,
A*33, A*68), and to the disruption of the linkage with the
putative genetic trait of low CD8+ T lymphocytes. It is
possible that haplotypes carrying these HLA-A alleles are
more recent in the evolutionary history of the C282Y
mutation. In the light of the present evolutionary hypoth-
esis it is intriguing why chromosomes bearing HFE-C282Y
and HLA-A*01, -A*02 or -A*03 alleles may have become
relatively common in the general population, considering
that low numbers of CD8+ T lymphocytes do not seem to
be an advantageous trait. One could speculate that a selec-
tive advantage of these haplotypes should be only
observed in heterozygozity, i.e., in combination with
other diverse haplotypes. In this context it would also be
interesting to know which haplotypes are found in the
vast number of apparently non-expressing C282Y
homozygous recently found in large population screen-
ings [37,38].
Implications of the evolutionary hypothesis on the clinical 
expression of HH
The evolutionary hypothesis proposed above could
explain the association found by others between the HLA
region and the iron overload. Studies conducted before
and after the discovery of the HFE, have shown a more
severe phenotype in patients carrying the ancestral HLA
haplotype A*03-B*07 or the HLA allele A*03 [16,19,32-
35]. Two independent studies where the number of copies
of the ancestral haplotype was analyzed showed a more
severe expression in patients carrying two copies of the
ancestral haplotype as compared to those with one copy
and those without [19,33].
The hypothesis advanced here does not explain differ-
ences between males and females. It is well known that
males are predominantly affected and present a more
severe iron accumulation [16,22,35], as also shown here,
and that the correlation of CD8+ T cells with iron stores is
only observed in males [16]. An attempt to explain gender
differences was recently reported based on different fre-
quencies of the HLA alleles and haplotypes [39]. Although
significant differences in the haplotype frequencies of
A*03-B*07 between males and females were found, these
did not correspond to differences in iron measures [39]. It
is possible that whatever the mechanisms involved in the
relationship between HLA, CD8+ T cells and iron over-
load, it is not so relevant in females as in males because
other factors may be involved. The recent description that
serum transferrin is a limiting resource for the size of the
MHC class I dependent lymphocyte pool, and that the
lowest transferrin levels are observed in males, may help
to explain the increased susceptibility of males to iron
overload [40].
Conclusion
There are now intensive efforts to understand the genetic
mechanisms involved in the control of T-lymphocyte
numbers [10,11]. The present results constitute a step for-
ward to narrowing the region in chromosome 6 to look
for a candidate gene involved in the regulation of CD8+ T-
lymphocyte numbers. Further studies with extended
genetic markers in the region may in future elucidate this
question. In addition, the present study corroborates the
previous hypothesis that gene(s) contributing to the clin-
ical heterogeneity observed in HH could be genes that
also control CD8+ T-cell numbers. The identification of a
putative gene controlling the CD8+ T-lymphocyte num-
bers may be of great relevance not only in the manage-
ment of hemochromatosis but also in other clinical
situations where iron and lymphocytes may be important
pathologic co-factors, such as in cancer and infection.
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